Success Metrics

Clinical Success Rate
91.7%

Based on 22 completed trials

Completion Rate
92%(22/24)
Active Trials
0(0%)
Results Posted
27%(6 trials)
Terminated
2(7%)

Phase Distribution

Ph not_applicable
3
10%
Ph phase_1
2
7%
Ph phase_2
5
17%
Ph phase_4
10
34%
Ph phase_3
8
28%
Ph early_phase_1
1
3%

Phase Distribution

3

Early Stage

5

Mid Stage

18

Late Stage

Phase Distribution29 total trials
Early Phase 1First-in-human
1(3.4%)
Phase 1Safety & dosage
2(6.9%)
Phase 2Efficacy & side effects
5(17.2%)
Phase 3Large-scale testing
8(27.6%)
Phase 4Post-market surveillance
10(34.5%)
N/ANon-phased studies
3(10.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.0%

22 of 25 finished

Non-Completion Rate

12.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

29

all time

Status Distribution
Active(1)
Completed(22)
Terminated(3)
Other(3)

Detailed Status

Completed22
unknown3
Terminated2
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
0
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.4%)
Phase 12 (6.9%)
Phase 25 (17.2%)
Phase 38 (27.6%)
Phase 410 (34.5%)
N/A3 (10.3%)

Trials by Status

terminated27%
withdrawn13%
unknown310%
not_yet_recruiting13%
completed2276%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT07467343Phase 4

Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial

Not Yet Recruiting
NCT07134907Phase 4

The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH

Completed
NCT06999135Not Applicable

Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones

Completed
NCT06381206Phase 1

Silodosin in Management of Lower Ureteral Stones

Completed
NCT06282731Early Phase 1

The Changes of Urine Growth Factors Level

Completed
NCT06114979Phase 3

Silodosin vs Placebo in the Treatment of Female LUTS

Unknown
NCT05823662Not Applicable

Double J Stenting and Sildosin After URSL for Lower Ureteric Stones

Completed
NCT05789732Not Applicable

Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones

Completed
NCT05790902Phase 1

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

Completed
NCT05570084Phase 3

Silodosin vs Tamsulosin as MET

Unknown
NCT02369744Phase 4

Silodosin Versus Tamsulosin for Treatment of Ureteral Stones

Terminated
NCT04107896Phase 4

Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Completed
NCT02106182Phase 4

Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia

Completed
NCT01560091Phase 3

Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy

Withdrawn
NCT02090439Phase 3

Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.

Terminated
NCT02581826Phase 2

Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation

Unknown
NCT01144949Phase 2

Study of Silodosin to Facilitate Passage of Urinary Stones

Completed
NCT01757769Phase 4

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia

Completed
NCT01533389Phase 4

Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

Completed
NCT01539265Phase 2

A Dose-finding Study of Silodosin in Patients With Urinary Calculi

Completed

Drug Details

Intervention Type
DRUG
Total Trials
29